NIH Active Patent Commercialization Licenses
Download a CSV of the complete license data set.
Reset the Search Filters to go back to the initial display of all records.
Questions? See the NIH Active Patent Commercialization Licenses FAQ.
| ID | Lead IC | Licensee | Territory | Exclusivity | Fiscal Year | Execution Date | Effective Date | Technology ID |
|---|---|---|---|---|---|---|---|---|
| L-106-2023 | NIAID | Changchun BCHT Biotechnology Co. | Foreign | Nonexclusive | 2023 | E-081-2013 E-064-2016 |
||
| L-091-2023 | NCI | Uereka Biosciences Inc. | Worldwide | Exclusive | 2023 | E-169-2021 E-187-2022 E-188-2022 E-189-2022 |
||
| L-023-2022 | NIAID | Thermo Fisher Scientific | Worldwide | Nonexclusive | 2023 | E-234-2016 E-086-2020 |
||
| L-049-2023 | NIAID | ModernaTX, Inc. | Worldwide | Nonexclusive | 2023 | E-234-2016 | ||
| L-179-2022 | NCI | MilliporeSigma | Worldwide | Nonexclusive | 2023 | E-198-2018 | ||
| L-014-2023 | NCI | Pangea Biomed, Ltd. | Worldwide | Nonexclusive | 2023 | E-150-2020 | ||
| L-190-2022 | NICHD | Gold Standard Phantoms Limited | US | Nonexclusive | 2023 | E-249-2008 | ||
| L-131-2022 | NIAID | Ceva Sante Animale S.A. | Worldwide | Nonexclusive | 2023 | E-081-2013 E-064-2016 |
||
| L-052-2018 | NCI | MedGene Therapeutics, Inc. | Worldwide | Exclusive | 2023 | E-085-2013 | ||
| L-218-2022 | NCI | Eureka Therapeutics, Inc. | Worldwide | Nonexclusive | 2022 | E-198-2018 E-048-2022 |
||
| L-258-2019 | NIAID | Vaccitech North America Inc. | Worldwide | Exclusive | 2022 | E-137-2018 E-191-2018 E-203-2020 E-213-2021 E-214-2021 E-216-2021 E-004-2022 E-025-2023 E-174-2023 |
||
| L-202-2022 | NCI | Bio X Cell, LLC | Worldwide | Nonexclusive | 2022 | E-198-2018 | ||
| L-203-2022 | NCI | Bio X Cell, LLC | Worldwide | Nonexclusive | 2022 | E-130-2011 | ||
| L-204-2022 | NCI | Bio X Cell, LLC | Worldwide | Nonexclusive | 2022 | E-198-2012 | ||
| L-205-2022 | NCI | Bio X Cell, LLC | Worldwide | Nonexclusive | 2022 | E-136-2012 | ||
| L-189-2022 | NCI | Gilead Sciences, Inc. | Worldwide | Exclusive | 2022 | E-103-2010 | ||
| L-188-2022 | NCI | Cell Signaling Technology, Inc. | Worldwide | Nonexclusive | 2022 | E-198-2018 | ||
| L-093-2005 | NIAID | Janssen Vaccines & Prevention B.V. | Worldwide | Exclusive | 2022 | E-552-1982 E-241-2001 E-246-2001 E-090-2002 E-185-2003 E-317-2003 E-319-2004 E-043-2011 E-076-2015 |
||
| L-154-2022 | NIAID | Big Eye Diagnostics, Inc. | Worldwide | Nonexclusive | 2022 | E-281-2010 E-093-2022 |
||
| L-164-2022 | NIAID | Grid Biosciences, LLC | Worldwide | Nonexclusive | 2022 | E-531-2013 | ||
| L-277-2018 | NIAID | Biological E Limited | Foreign | Nonexclusive | 2022 | E-217-2004 | ||
| L-172-2022 | NCATS | Tocris Cookson Ltd. | Worldwide | Nonexclusive | 2022 | E-326-2008 | ||
| L-107-2015 | NCI | Iovance Biotherapeutics. Inc. | Worldwide | Exclusive | 2022 | E-275-2002 E-170-2009 E-273-2009 E-114-2011 E-059-2013 E-085-2013 E-494-2013 E-068-2018 E-094-2018 E-167-2019 E-061-2020 E-102-2020 |
||
| L-158-2022 | NCI | MilliporeSigma | Worldwide | Nonexclusive | 2022 | E-264-2015 | ||
| L-028-2019 | NIAID | Ridgeback Biotherapeutics | Worldwide | Exclusive | 2022 | E-045-2015 |